Seguir
Alexandra Foulkes, JD, MSc
Alexandra Foulkes, JD, MSc
Afiliación desconocida
Dirección de correo verificada de bcm.edu
Título
Citado por
Citado por
Año
Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial
JW Murrough, DV Iosifescu, LC Chang, RK Al Jurdi, CE Green, AM Perez, ...
American Journal of Psychiatry 170 (10), 1134-1142, 2013
12722013
Effects of ketamine on explicit and implicit suicidal cognition: A randomized controlled trial in treatment‐resistant depression
RB Price, DV Iosifescu, JW Murrough, LC Chang, RK Al Jurdi, SZ Iqbal, ...
Depression and anxiety 31 (4), 335-343, 2014
3602014
Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression
CN Haile, JW Murrough, DV Iosifescu, LC Chang, RK Al Jurdi, A Foulkes, ...
International Journal of Neuropsychopharmacology 17 (2), 331-336, 2014
2572014
Ketamine safety and tolerability in clinical trials for treatment-resistant depression
LB Wan, CF Levitch, AM Perez, JW Brallier, DV Iosifescu, LC Chang, ...
The Journal of clinical psychiatry 76 (3), 10121, 2014
2342014
Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial
JW Murrough, KE Burdick, CF Levitch, AM Perez, JW Brallier, LC Chang, ...
Neuropsychopharmacology 40 (5), 1084-1090, 2015
1422015
Legal and ethical implications of CRISPR applications in psychiatry
AL Foulkes, T Soda, M Farrell, P Giusti-Rodríguez, G Lázaro-Muñoz
North Carolina law review 97 (5), 1359, 2019
222019
Preventing undue discrimination based on psychiatric risk biomarkers
C Brennan, G Foulkes, A., Lazaro-Munoz
Am J Med Genet Part B, 1-13, 2018
17*2018
Genetic duties
JL Roberts, AL Foulkes
Wm. & Mary L. Rev. 62, 143, 2020
142020
The impact of brain‐derived neurotrophic factor Val66Met polymorphism on cognition and functional brain networks in patients with intractable partial epilepsy
MK Sidhu, PJ Thompson, B Wandschneider, A Foulkes, J De Tisi, ...
CNS Neuroscience & Therapeutics 25 (2), 223-232, 2019
132019
Can clinical genetics laboratories be sued for medical malpractice?
AL Foulkes, JL Roberts, PS Appelbaum, WK Chung, EW Clayton, B Evans, ...
Annals of health law and life sciences 29 (1), 153, 2020
22020
Liberty's Limits & Editing Humanity
AL Foulkes
NCL Rev. Addendum 98, 1549, 2019
12019
Effects of Intravenous Ketamine on Explicit and Implicit Suicdal Cognition: A Randomized Controlled Trial in Treatment-Resistant Depression
R Price, DV Iosifescu, JW Murrough, LC Chang, RK Al Jurdi, DS Charney, ...
BIOLOGICAL PSYCHIATRY 73 (9), 142S-143S, 2013
12013
Genetic Villains
AL Foulkes
SCL Rev. 73, 1, 2021
2021
The Evolutionary Tradition in Law & Metaphor's Double-Edged Sword
AL Foulkes
Hous. L. Rev. 56, 223, 2018
2018
Clinical Moderators of Antidepressant Response to Ketamine: A Bayesian Analysis
AL Foulkes, CE Green, JW Murrough, LC Chang, RK Al Jurdi, ...
BIOLOGICAL PSYCHIATRY 75 (9), 126S-126S, 2014
2014
Ketamine for treatment-resistant depression: Subjective effects and impact on plasma brain-derived neurotrophic factor
CN Haile, JJ Murrough, DV Iosifescu, LC Chang, RK Al Jurdi, A Foulkes, ...
Drug and Alcohol Dependence, e77, 2014
2014
DOES THE BDNF VAL66MET POLYMORPHISM INFLUENCE COGNITIVE FUNCTION IN PATIENTS WITH MTLE?
J Stretton, A Foulkes, PJ Thompson, S Baxendale, MK Sidhu, E Williams, ...
EPILEPSIA 53, 39-39, 2012
2012
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–17